166 related articles for article (PubMed ID: 27135108)
1. [Aspects of pathogenetc pharmacotherapy for portal hypertension in liver cirrhosis].
Garbuzenko DV
Ter Arkh; 2016; 88(2):101-108. PubMed ID: 27135108
[TBL] [Abstract][Full Text] [Related]
2. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.
Garbuzenko DV
World J Gastroenterol; 2015 May; 21(20):6117-26. PubMed ID: 26034348
[TBL] [Abstract][Full Text] [Related]
3. [Medical therapy of portal hypertension due to liver cirrhosis].
Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
[TBL] [Abstract][Full Text] [Related]
4. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
[TBL] [Abstract][Full Text] [Related]
5. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
Gatta A; Bolognesi M; Sacerdoti D; Merkel C
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
[TBL] [Abstract][Full Text] [Related]
6. [Clinico-pathogenetic and pharmacotherapeutic aspects of portal hypertension in liver cirrhosis].
Ryss ES; Fishzon-Ryss IuI
Ter Arkh; 1989; 61(8):65-8. PubMed ID: 2686074
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
[No Abstract] [Full Text] [Related]
8. [Complications of portal hypertension in the liver cirrhosis].
Ivashkin VT
Ross Fiziol Zh Im I M Sechenova; 2009 Oct; 95(10):1074-92. PubMed ID: 19957897
[TBL] [Abstract][Full Text] [Related]
9. [Hemodynamic disorders due to liver cirrhosis].
Garbuzenko DV
Klin Med (Mosk); 1996; 74(2):5-7. PubMed ID: 8772089
[No Abstract] [Full Text] [Related]
10. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
García-Pagán JC; Gracia-Sancho J; Bosch J
J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
[No Abstract] [Full Text] [Related]
11. Pharmacological treatment of portal hypertension.
González-Abraldes J; Bosch J; García-Pagán JC
Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
[TBL] [Abstract][Full Text] [Related]
12. [Physiopathology of portal hypertension in liver cirrhosis].
Cervela LA
Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
[No Abstract] [Full Text] [Related]
13. Damping index of Doppler hepatic vein waveform to assess the severity of portal hypertension and response to propranolol in liver cirrhosis: a prospective nonrandomized study.
Kim MY; Baik SK; Park DH; Lim DW; Kim JW; Kim HS; Kwon SO; Kim YJ; Chang SJ; Lee SS
Liver Int; 2007 Oct; 27(8):1103-10. PubMed ID: 17845539
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacotherapy of portal hypertension and its complications: analysis of efficacy of preparations for clinical practice and discussion of promising methods of treatment].
Pavlov ChS; Maevskaia MV; Kitsenko EA; Kovtun VV; Ivashkin VT
Klin Med (Mosk); 2013; 91(6):55-62. PubMed ID: 24417070
[TBL] [Abstract][Full Text] [Related]
16. Liver surgery in cirrhosis and portal hypertension.
Hackl C; Schlitt HJ; Renner P; Lang SA
World J Gastroenterol; 2016 Mar; 22(9):2725-35. PubMed ID: 26973411
[TBL] [Abstract][Full Text] [Related]
17. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
Thalheimer U; Bellis L; Puoti C; Burroughs AK
Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic changes and its significance after liver transplantation for cirrhosis and portal hypertension].
Zhang TL
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1689-92. PubMed ID: 19094724
[No Abstract] [Full Text] [Related]
19. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
20. Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis.
Dumont AE; Witte CL; Witte MH
Lymphology; 1975 Dec; 8(4):111-3. PubMed ID: 1214504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
